Related Experiment Video
Updated: Aug 9, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!]
G Barbé1, C Ploton, C Pondarré
1Laboratoire de Bactériologie, Faculté de Pharmacie (UPRES-EA 1655), Hôpital Debrousse, Lyon, France.
Insights
Immunocompromised children carrying vancomycin-resistant enterococci (VRE) may not require eradication treatment. Strict hygiene measures are crucial, as VRE colonization did not lead to bacteremia in this study.
Area of Science:
- Infectious Diseases
- Microbiology
- Pediatric Oncology
Context:
- Investigating vancomycin-resistant enterococci (VRE) colonization in immunocompromised children undergoing chemotherapy or bone-marrow transplantation (BMT).
- Evaluating decontamination protocols including amikacin and vancomycin mouth rinses.
- Monitoring VRE carriage in a cohort of 230 pediatric patients over three years.
Purpose:
- To determine if treatment is necessary for immunocompromised children colonized with VRE.
- To assess the risk of VRE bacteremia in this patient population.
- To evaluate the efficacy of gut decontamination strategies.
Summary:
- Four pediatric patients with chemotherapy/BMT were identified as VRE carriers.
- Fecal VRE carriage was persistent in one patient, with failed eradication attempts.
- No VRE bacteremia occurred in any of the VRE-colonized patients.
Impact:
- Suggests that VRE eradication may not be necessary in immunocompromised pediatric patients.
- Highlights the importance of strict adherence to hygienic measures to prevent VRE complications.
- Informs clinical decision-making regarding VRE management in vulnerable pediatric populations.
Abstract:
Do immunocompromised children, carrying vancomycin-resistant enterococci (VRE) need to be treated? For 3 years, 230 children with chemotherapy and/or bone-marrow transplantation (BMT) received amikacin for gut decontamination and rinsed their mouth with solutions including vancomycin or not, according to the duration and severity of neutropenia. Some patients were isolated, others were at home with ambulatory treatment. The first-line antibio-therapy was piperacillin-amikacin-vancomycin in the chemotherapy unit, imipenem-vancomycin in the BMT unit. Once-a-week, the laboratory used to check the efficiency of decontamination procedures and look for emerging resistant bacteria. Four patients were identified as VRE carriers in their gut flora. The fecal carriage was long-lasting in a single patient, for whom attempts of eradication failed. No patient underwent VRE bacteremia. From our experience, it seems reasonable to neglect enterococcal eradication, provided that hygienic measures are strictly applied.
Related Concept Videos
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Drug Dosing: Infants and Children
Endocarditis IV: Nursing Management
Urinary Tract Infection IV: Nursing Management
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance

